Differing coagulation profiles of patients with monoclonal gammopathy of undetermined significance and multiple myeloma

Venous Thromboembolism in Patients With Myeloma

(2014) Maeve P. Crowley et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Assessment of rotation thromboelastometry (ROTEM) parameters in patients with multiple myeloma at diagnosis

(2014) Jacek Treliński et al.   THROMBOSIS RESEARCH

Prolonged prothrombin time correlates with serum monoclonal protein concentration in patients with plasma cell dyscrasia

(2012) S. Pandey et al.   International Journal of Laboratory Hematology

A retrospective cohort study of venous thromboembolism(VTE) in 1035 Japanese myeloma patients treated with thalidomide; lower incidence without statistically significant association between specific risk factors and development of VTE and effects of thromboprophylaxis with aspirin and warfarin

(2012) Atsushi Kato et al.   THROMBOSIS RESEARCH

Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide

(2011) A. Larocca et al.   BLOOD

Thrombosis in Multiple Myeloma

(2011) S. Y. Kristinsson   Hematology-American Society of Hematology Education Program

Prediction of venous thromboembolism in cancer patients

(2010) C. Ay et al.   BLOOD

Monoclonal gammopathy of undetermined significance and risk of venous thromboembolism

(2010) Henrik Gregersen et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma

(2008) S. Y. Kristinsson et al.   BLOOD

Thalidomide for treatment of multiple myeloma: 10 years later

(2008) A. Palumbo et al.   BLOOD

Development and validation of a predictive model for chemotherapy-associated thrombosis

(2008) A. A. Khorana et al.   BLOOD